These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3833387)

  • 41. [Further observations on the inhibitory effect of rheumatoid plasma: reduction in the production of rosette forming cells by normal lymphocytes].
    Semenzato G; Amadori G; Tosato F; Sarasin P; Gasparotto G
    Reumatismo; 1977; 29(2-3):184-6. PubMed ID: 616966
    [No Abstract]   [Full Text] [Related]  

  • 42. Activity of synthetic thymosin alpha 1 C-terminal peptides in the azathioprine E-rosette inhibition assay.
    Ciardelli TL; Incefy GS; Birr C
    Biochemistry; 1982 Aug; 21(18):4233-7. PubMed ID: 6982069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Refractoriness of mouse spleen rosette-forming cells to thymus hormones during the period of early postnatal ontogeny].
    Giulling EV; Nikol'skiĭ IS; Kravchuk GP; Ovsienko VV; Khaloimova IL
    Ontogenez; 1981; 12(1):100-2. PubMed ID: 7197341
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The synthesis of peptides with potential thymic hormone activity: the synthesis of endo-Arg38a-deacetylthymosin beta 10.
    Abiko T; Sekino H
    Biotechnol Appl Biochem; 1987 Feb; 9(1):20-30. PubMed ID: 3494463
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of thymosin-responsive peripheral blood null cells.
    Kaplan J
    Cancer Treat Rep; 1978 Nov; 62(11):1757-61. PubMed ID: 310342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. On the molecular size of thymosins.
    Haritos AA; Yialouris PP; Heimer EP; Felix AM; Rosemeyer MA
    FEBS Lett; 1987 Jun; 218(1):107-12. PubMed ID: 3595856
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of thymosin on the capacity of heated guinea pig thymocytes for rosette formation].
    Sambur MB; Kravchuk GP
    Fiziol Zh (1978); 1979; 25(6):739-41. PubMed ID: 315888
    [No Abstract]   [Full Text] [Related]  

  • 48. Immunological effect of two synthetic peptides containing alanine or D-alanine instead of acetyl group of thymosin beta 4 after treatment of human serum.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2602-5. PubMed ID: 2285992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis of deacetylthymosin beta 11 and its effect on the impaired T-lymphocytes of a uremic patient with common variable immunodeficiency.
    Abiko T; Sekino H
    Biotechnol Appl Biochem; 1988 Dec; 10(6):576-88. PubMed ID: 3266074
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of thymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients.-II) In vivo study.
    Auteri A; Laghi Pasini F; Pasqui AL; Bilenchi R; Di Perri T
    Boll Soc Ital Biol Sper; 1980 Feb; 56(4):312-5. PubMed ID: 7018515
    [No Abstract]   [Full Text] [Related]  

  • 51. Thymosins: structure, function and therapeutic applications.
    Low TL; Goldstein AL
    Thymus; 1984; 6(1-2):27-42. PubMed ID: 6087503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of thymosin alpha 1 on prostaglandin release by murine lymphocytes].
    Baldassarre AM; Stirparo G; Palamara AT; Padovani A; Mastino A
    Boll Soc Ital Biol Sper; 1985 Jan; 61(1):23-6. PubMed ID: 3856433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of polymorphonucleate-mediated cytotoxicity against Candida albicans by thymosin alpha 1.
    Bistoni F; Baccarini M; Blasi E; Riccardi C; Marconi P; Garaci E
    Thymus; 1985; 7(2):69-84. PubMed ID: 3892779
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [In vitro effect of calf thymosin on T cell of cancer patients].
    Ye M
    Zhonghua Zhong Liu Za Zhi; 1982 Nov; 4(4):245-8. PubMed ID: 6984676
    [No Abstract]   [Full Text] [Related]  

  • 55. In vitro thymosin effect on T lymphocytes in ankylosing spondylitis.
    Mutchnick MG; Good AE; Barlas N; Goldstein AL
    Thymus; 1981 Dec; 3(6):377-81. PubMed ID: 6976651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduced Fc-receptor bearing cells in peripheral bloods of patients with systemic lupus erythematosus and in rheumatoid synovial fluids.
    Nakai H; Morito T; Tanimoto K; Horiuchi Y
    J Rheumatol; 1977; 4(4):405-13. PubMed ID: 415139
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diminished synthesis of immunoglobulins by lymphocytes of patients treated with thymosin (TFX) and cyclophosphamide.
    Gorski A; Rancewicz Z; Nowaczyk M; Malejczyk M; Waski M
    Adv Exp Med Biol; 1983; 166():79-88. PubMed ID: 6650285
    [No Abstract]   [Full Text] [Related]  

  • 58. [Correlation between the rheumatoid rosette test and the clinical picture of rheumatoid arthritis (author's transl)].
    Domljan Z; Horvat Z
    Lijec Vjesn; 1981 Jun; 103(6):245-7. PubMed ID: 6976498
    [No Abstract]   [Full Text] [Related]  

  • 59. Production of biologically active N alpha-desacetylthymosin alpha 1 in Escherichia coli through expression of a chemically synthesized gene.
    Wetzel R; Heyneker HL; Goeddel DV; Jhurani P; Shapiro J; Crea R; Low TL; McClure JE; Thurman GB; Goldstein AL
    Biochemistry; 1980 Dec; 19(26):6096-104. PubMed ID: 7008828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The "active" rosette test in rheumatoid arthritis: correlation with disease activity.
    Espinoza LR; Gaylord SW; Bergen L; Vasey FB; Germain BF; Osterland CK
    Clin Immunol Immunopathol; 1980 Sep; 17(1):110-6. PubMed ID: 7408235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.